108 related articles for article (PubMed ID: 6496734)
1. Reduced and S-carboxymethylated human growth hormone: a probe for diabetogenic action.
Cameron CM; Kostyo JL; Rillema JA; Gennick SE
Am J Physiol; 1984 Nov; 247(5 Pt 1):E639-44. PubMed ID: 6496734
[TBL] [Abstract][Full Text] [Related]
2. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
[TBL] [Abstract][Full Text] [Related]
3. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
Adamafio NA; Cameron CM; Kostyo JL
Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
Towns R; Kostyo JL; Colca JR
Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
6. Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities.
Kostyo JL; Cameron CM; Olson KC; Jones AJ; Pai RC
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4250-3. PubMed ID: 3889926
[TBL] [Abstract][Full Text] [Related]
7. A hybrid noncovalent complex of fragments of porcine and human growth hormones with diabetogenic activity.
Gennick SE; Kostyo JL; Mills JB; Eden S
Endocrinology; 1983 Jun; 112(6):2069-75. PubMed ID: 6303758
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of S-carboxymethylated human growth hormone on insulin resistance in the obese (ob/ob) mouse.
Adamafio NA; Kostyo JL; Cameron CM; Trimark JR; Dunbar JC
Metabolism; 1988 Sep; 37(9):900-5. PubMed ID: 3047525
[TBL] [Abstract][Full Text] [Related]
9. The stimulatory effect of insulin on diacylglycerol generation in adipocyte membranes from ob/ob mice is impaired by growth hormone.
Towns R; Kostyo JL; Martin D; Chou SY; Bennink MR
Endocrinology; 1993 Apr; 132(4):1671-6. PubMed ID: 8462467
[TBL] [Abstract][Full Text] [Related]
10. Diabetogenic activity of native and biosynthetic human growth hormone in obese (ob/ob) mouse.
Kostyo JL; Gennick SE; Sauder SE
Am J Physiol; 1984 Apr; 246(4 Pt 1):E356-60. PubMed ID: 6720889
[TBL] [Abstract][Full Text] [Related]
11. Trypsin-resistant forms of human growth hormone have diabetogenic and insulin-like activities.
Cameron CM; Kostyo JL; Kumar V; Gennick SE
Biochim Biophys Acta; 1985 Sep; 841(3):254-60. PubMed ID: 3896320
[TBL] [Abstract][Full Text] [Related]
12. 20-kDa placental hGH-V has diminished diabetogenic and lactogenic activities compared with 22-kDa hGH-N while retaining antilipogenic activity.
Vickers MH; Gilmour S; Gertler A; Breier BH; Tunny K; Waters MJ; Gluckman PD
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E629-37. PubMed ID: 19509186
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of plasmin digests of human growth hormone in the rat and man.
Mills JB; Reagan CR; Rudman D; Kostyo JL; Zachariah P; Wilhelmi AE
J Clin Invest; 1973 Nov; 52(11):2941-51. PubMed ID: 4270645
[TBL] [Abstract][Full Text] [Related]
14. A recombinant-DNA-derived modification of human growth hormone (hGH44-191) with enhanced diabetogenic activity.
Lewis UJ; Lewis LJ; Salem MA; Staten NR; Galosy SS; Krivi GG
Mol Cell Endocrinol; 1991 Jun; 78(1-2):45-54. PubMed ID: 1936524
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone inhibits activation of phosphatidylinositol phospholipase C by insulin in ob/ob mouse adipose tissue.
Chou SY; Kostyo JL; Adamafio NA
Endocrinology; 1990 Jan; 126(1):62-6. PubMed ID: 2403523
[TBL] [Abstract][Full Text] [Related]
17. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats.
Salem MA
Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372
[TBL] [Abstract][Full Text] [Related]
18. The acute effects of growth hormone on amino acid transport and protein synthesis are due to its insulin-like action.
Cameron CM; Kostyo JL; Adamafio NA; Brostedt P; Roos P; Skottner A; Forsman A; Fryklund L; Skoog B
Endocrinology; 1988 Feb; 122(2):471-4. PubMed ID: 3276499
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.
Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T
Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826
[TBL] [Abstract][Full Text] [Related]
20. Lipolytic and antilipolytic effects of human growth hormone, its 20-kilodalton variant, a reduced and carboxymethylated derivative, and human placental lactogen on chicken adipose tissue in vitro.
Campbell RM; Kostyo JL; Scanes CG
Proc Soc Exp Biol Med; 1990 Apr; 193(4):269-73. PubMed ID: 2320598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
